2010
DOI: 10.1002/ajh.21887
|View full text |Cite
|
Sign up to set email alerts
|

C‐MYC rearrangement may induce an aggressive phenotype in anaplastic lymphoma kinase positive anaplastic large cell lymphoma: Identification of a novel fusion gene ALO17/C‐MYC

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
19
0

Year Published

2014
2014
2020
2020

Publication Types

Select...
6
4

Relationship

0
10

Authors

Journals

citations
Cited by 30 publications
(20 citation statements)
references
References 27 publications
0
19
0
Order By: Relevance
“…Rnf213 and Htr3b were both downregulated in the GL group. Rnf213 encodes a protein with ring finger domain and it is involved in chromosomal arrangement with c-Myc and ALK in anaplastic large cell lymphoma, and with SLC26A11 in chronic myeloid leukemia [48][49][50].…”
Section: Discussionmentioning
confidence: 99%
“…Rnf213 and Htr3b were both downregulated in the GL group. Rnf213 encodes a protein with ring finger domain and it is involved in chromosomal arrangement with c-Myc and ALK in anaplastic large cell lymphoma, and with SLC26A11 in chronic myeloid leukemia [48][49][50].…”
Section: Discussionmentioning
confidence: 99%
“…on May 10, 2018. by guest www.bloodjournal.org From RNF213 itself may play an important role in oncogenesis. 55,56 It is important to note that most CNAs were consistent with heterozygous loss, and classical tumor suppressors require biallelic loss for oncogenesis. However, these losses could lead to pathway modulation due to altered protein levels or the creation of dominant negatives by partial gene loss.…”
Section: Discussionmentioning
confidence: 99%
“…Using deep RNA sequencing, our group recently identified a novel TRAF1-ALK fusion in an ALCL patient with cytoplasmic ALK immunoreactivity only [9]. Rearrangements of the MYC gene, frequently detected in high-grade B-cell lymphomas, have been reported in 3 cases of ALK-positive ALCL [1012]. All 3 patients with dual ALK and MYC rearrangements demonstrated an aggressive clinical course, with systemic and extranodal presentation, early tumor relapse, and bone marrow involvement during the course of the disease.…”
Section: Alk Rearrangementsmentioning
confidence: 99%